Table 3.
Summary of the number of isolates by ESKAPE pathogens and the total number of BSI cases due to these pathogens with related resistance profiles (data available on SENTRY dataset).
| Pathogen | n. Cases of Infections (n = Number) |
n. BSIs Reported (n = Number) |
Frequent Resistance Profiles in BSIs |
|---|---|---|---|
| Enterococcus spp. | 15,022 | 5154 | Van-A |
| S. aureus | 69,918 | 13,608 | MRSA (less frequent VRSA) |
| K. pneumoniae | 26,701 | 6901 | NMD-1 |
| Acinetobacter spp. | 7151 | 1372 | IMP and OXA |
| P. aeruginosae | 28,096 | 3264 | ESBLs, KPC, VIM and IMP |
| Enterobacter spp. | 11,597 | 2241 | ESBLs |
Abbreviations—Van-A: vancomycin and teicoplanin resistance pattern; MRSA: methicillin-resistant S. aureus; VRSA: vancomycin resistant S. aureus; NMD-1: New Delhi metallo-beta-lactamase; IMP: imipenem metallo-beta-lactamases; OXA: oxacillinase serine beta-lactamases; ESBLs: extended spectrum beta-lactamases; KPC: K. pneumoniae carbapenemase; VIM: Verona integron-encoded metallo β-lactamases.